Cargando…
‘Care for Outcomes’: systematic development of a set of outcome indicators to improve patient-relevant outcomes for patients with lung cancer
OBJECTIVES: Measuring quality of care is important, however many of the quality indicators used do not focus on outcome of treatment and aspects which are valuable for patients and physicians. The project ‘Care for Outcomes’ aims to establish a relevant set of outcome indicators for lung cancer. SET...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7813396/ https://www.ncbi.nlm.nih.gov/pubmed/33452199 http://dx.doi.org/10.1136/bmjopen-2020-043229 |
_version_ | 1783637840522903552 |
---|---|
author | Cramer-van der Welle, Christine M van Loenhout, Lotte van den Borne, Ben EEM Schramel, Franz MNH Dijksman, Lea M |
author_facet | Cramer-van der Welle, Christine M van Loenhout, Lotte van den Borne, Ben EEM Schramel, Franz MNH Dijksman, Lea M |
author_sort | Cramer-van der Welle, Christine M |
collection | PubMed |
description | OBJECTIVES: Measuring quality of care is important, however many of the quality indicators used do not focus on outcome of treatment and aspects which are valuable for patients and physicians. The project ‘Care for Outcomes’ aims to establish a relevant set of outcome indicators for lung cancer. SETTING: Network of seven large, non-university teaching hospitals in the Netherlands (Santeon). METHODS: By reviewing the literature, a list of potential outcome indicators for patients with lung cancer was composed and subsequently prioritised by expert’s opinion. Three external parties, with expertise on lung cancer, clinical management and public health, evaluated and reduced the list of indicators to a working set. Finally, the resulting selection of outcome indicators was tested for feasibility and discrimination in patient data, by collecting retrospective data and performing regression and survival analyses. PARTICIPANTS: Development of the indicator set in six Santeon hospitals. Retrospective cohort study in 5922 patients diagnosed with lung cancer (all types and stages). RESULTS: Selected outcome indicators were divided into three levels of outcome (tiers). The first tier about survival and the process of recovery include mortality, survival, positive resection margins, rethoracotomy after resection and quality of life at baseline and after 3, 6 and 12 months. Tier 2 concerning the sustainability of the recovery include complications after resection and toxicity after chemotherapy and/or radiation. Tier 3 about sustainability of health revealed no measurable outcomes. The retrospective data collection showed differences between hospitals and variation in case mix. CONCLUSION: A relevant set of outcome indicators for lung cancer was systematically developed. This set has the potential to compare quality of care between hospitals and inform patients with lung cancer about outcomes. The project is ongoing in the current Santeon Value-Based Health Care programme through quality and improvement cycles. |
format | Online Article Text |
id | pubmed-7813396 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | BMJ Publishing Group |
record_format | MEDLINE/PubMed |
spelling | pubmed-78133962021-01-25 ‘Care for Outcomes’: systematic development of a set of outcome indicators to improve patient-relevant outcomes for patients with lung cancer Cramer-van der Welle, Christine M van Loenhout, Lotte van den Borne, Ben EEM Schramel, Franz MNH Dijksman, Lea M BMJ Open Oncology OBJECTIVES: Measuring quality of care is important, however many of the quality indicators used do not focus on outcome of treatment and aspects which are valuable for patients and physicians. The project ‘Care for Outcomes’ aims to establish a relevant set of outcome indicators for lung cancer. SETTING: Network of seven large, non-university teaching hospitals in the Netherlands (Santeon). METHODS: By reviewing the literature, a list of potential outcome indicators for patients with lung cancer was composed and subsequently prioritised by expert’s opinion. Three external parties, with expertise on lung cancer, clinical management and public health, evaluated and reduced the list of indicators to a working set. Finally, the resulting selection of outcome indicators was tested for feasibility and discrimination in patient data, by collecting retrospective data and performing regression and survival analyses. PARTICIPANTS: Development of the indicator set in six Santeon hospitals. Retrospective cohort study in 5922 patients diagnosed with lung cancer (all types and stages). RESULTS: Selected outcome indicators were divided into three levels of outcome (tiers). The first tier about survival and the process of recovery include mortality, survival, positive resection margins, rethoracotomy after resection and quality of life at baseline and after 3, 6 and 12 months. Tier 2 concerning the sustainability of the recovery include complications after resection and toxicity after chemotherapy and/or radiation. Tier 3 about sustainability of health revealed no measurable outcomes. The retrospective data collection showed differences between hospitals and variation in case mix. CONCLUSION: A relevant set of outcome indicators for lung cancer was systematically developed. This set has the potential to compare quality of care between hospitals and inform patients with lung cancer about outcomes. The project is ongoing in the current Santeon Value-Based Health Care programme through quality and improvement cycles. BMJ Publishing Group 2021-01-15 /pmc/articles/PMC7813396/ /pubmed/33452199 http://dx.doi.org/10.1136/bmjopen-2020-043229 Text en © Author(s) (or their employer(s)) 2021. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. http://creativecommons.org/licenses/by-nc/4.0/ http://creativecommons.org/licenses/by-nc/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/. |
spellingShingle | Oncology Cramer-van der Welle, Christine M van Loenhout, Lotte van den Borne, Ben EEM Schramel, Franz MNH Dijksman, Lea M ‘Care for Outcomes’: systematic development of a set of outcome indicators to improve patient-relevant outcomes for patients with lung cancer |
title | ‘Care for Outcomes’: systematic development of a set of outcome indicators to improve patient-relevant outcomes for patients with lung cancer |
title_full | ‘Care for Outcomes’: systematic development of a set of outcome indicators to improve patient-relevant outcomes for patients with lung cancer |
title_fullStr | ‘Care for Outcomes’: systematic development of a set of outcome indicators to improve patient-relevant outcomes for patients with lung cancer |
title_full_unstemmed | ‘Care for Outcomes’: systematic development of a set of outcome indicators to improve patient-relevant outcomes for patients with lung cancer |
title_short | ‘Care for Outcomes’: systematic development of a set of outcome indicators to improve patient-relevant outcomes for patients with lung cancer |
title_sort | ‘care for outcomes’: systematic development of a set of outcome indicators to improve patient-relevant outcomes for patients with lung cancer |
topic | Oncology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7813396/ https://www.ncbi.nlm.nih.gov/pubmed/33452199 http://dx.doi.org/10.1136/bmjopen-2020-043229 |
work_keys_str_mv | AT cramervanderwellechristinem careforoutcomessystematicdevelopmentofasetofoutcomeindicatorstoimprovepatientrelevantoutcomesforpatientswithlungcancer AT vanloenhoutlotte careforoutcomessystematicdevelopmentofasetofoutcomeindicatorstoimprovepatientrelevantoutcomesforpatientswithlungcancer AT vandenbornebeneem careforoutcomessystematicdevelopmentofasetofoutcomeindicatorstoimprovepatientrelevantoutcomesforpatientswithlungcancer AT schramelfranzmnh careforoutcomessystematicdevelopmentofasetofoutcomeindicatorstoimprovepatientrelevantoutcomesforpatientswithlungcancer AT dijksmanleam careforoutcomessystematicdevelopmentofasetofoutcomeindicatorstoimprovepatientrelevantoutcomesforpatientswithlungcancer |